31st October 2017

ReNeuron awarded additional grant funding

Bridgend-based cell therapy company ReNeuron has been awarded a further grant from the Welsh Government.

The funding has been awarded under the Welsh Government’s SMARTExpertise scheme and will help fund a £1.2m collaborative programme of work to be undertaken by ReNeuron, Ig Innovations and Swansea University Medical School.

The programme aims to support the development of the company’s exosome therapy platform, including refining the manufacturing process.

The latest grant follows a previous award from Innovate UK to develop manufacturing systems and to conduct pre-clinical testing relating to the ReNeuron’s exosome therapy platform.

Dr Randolph Corteling, head of research at ReNeuron, said: “We are delighted to have won this new grant under the Welsh Government’s SMARTExpertise scheme.

“As a Wales-based business, we are very pleased to be able to work with leading Welsh academic and industry collaborators in order to further progress development of our high-potential exosome therapy platform towards clinical application.”